A Case of Early Disseminated Neurological Lyme Disease Followed by Atypical Cutaneous Manifestations.
Vamsi Krishna KantamaneniVikas SunderMohammad BilalScott VargoPublished in: Case reports in infectious diseases (2017)
Lyme disease (LD) is a tick-borne illness caused by Borrelia burgdorferi sensu stricto. An 80-year-old female from Pennsylvania, USA, presented to an outside hospital with fever, confusion, lower extremity weakness, and stool incontinence. CT head and MRI spine were unremarkable. An infectious work-up including lumbar puncture was negative. She was transferred to our tertiary care hospital. Patient was noted to have mild unilateral right-sided facial droop and a diffuse macular rash throughout the body. She denied any outdoor activities, tick bites, or previous rash. Intravenous ceftriaxone was started for suspected LD. The patient's symptoms including facial droop resolved within 24 hours of antibiotic therapy. Polymerase chain reaction of the blood, IgM ELISA, and IgM Western blot testing for LD came back positive a few days after initiation of therapy. She was treated for a total of 21 days for neurological LD with complete symptom resolution. Not all patients have the classic "targetoid" EM rash on initial presentation, rash could develop after neurological manifestations, and prompt initiation of antibiotics without awaiting serology is paramount to making a quick and a full recovery. There should be a high index of suspicion for early disseminated LD, as presentations can be atypical.
Keyphrases
- case report
- tertiary care
- newly diagnosed
- contrast enhanced
- end stage renal disease
- healthcare
- ejection fraction
- magnetic resonance imaging
- chronic kidney disease
- computed tomography
- adverse drug
- minimally invasive
- south africa
- air pollution
- pulmonary embolism
- low grade
- soft tissue
- high dose
- physical activity
- stem cells
- emergency department
- diabetic retinopathy
- patient reported
- mesenchymal stem cells
- particulate matter
- ultrasound guided
- low dose
- diffusion weighted imaging
- blood brain barrier
- monoclonal antibody
- positron emission tomography
- subarachnoid hemorrhage
- brain injury